Q&A Session for Gastrointestinal and Pediatrics with Theodore Hong, MD, Emma Holiday, MD, and Julie Bradley, MD.

This course reviews the treatment guidelines for children with the most common benign and malignant tumors of childhood, with a focus on radiotherapy. Indications for radiotherapy are discussed, in addition to radiotherapy planning guidelines.

Upper GI
The management of upper GI cancers remains complex, multidisciplinary, and rapidly changing. In this session, we will review the current data from randomized trials that have affected standard of care in upper GI cancers.

This course is designed to provide clinicians in practice and trainees with a comprehensive review and update of the clinical practice parameters across most sub-disciplines of radiation oncology, including sarcomas, pediatrics and the role of radiotherapy in the multidisciplinary management of c

This session will review the latest science in the field of head and neck cancer.

Patients treated for head and neck cancers have a high rate of loco-regional recurrence and metastases. The current standards of care are largely based on institutional data or small multi-institutional retrospective collaborative series.

This session will review the current approaches to managing salivary cancers and the systemic treatment for recurrent or metastatic salivary cancers.

This session will examine the current state of evidence surrounding de-escalation of treatment in patients HPV-associated oropharyngeal cancer.

David Burkett is employed by The Burkett Law Firm and has stock ownership in Abbvie and Eli Lily.

This session reviews head and neck cancer from a patient perspective.

This session entitled the “Development of Survivorship Programs” will present a practical approach to developing a Survivorship Program and embed survivorship strategies in the entire continuum of care for the head and neck cancer patient.  The session will be divided into three main areas: